Valeria.Panebianco@uniroma1.it's picture

CORSO DI LAUREA "A" - DIAGNOSTICA PER IMMAGINI: 

- Orario Lezioni: https://corsidilaurea.uniroma1.it/it/corso/2020/30891/programmazione

- Link di accesso: https://corsidilaurea.uniroma1.it/it/node/2452830

 

CORSO DI LAUREA "F" - DIAGNOSTIC IMAGING:

Cari Studenti,

tutte le lezioni e le notizie relative alla didattica sono sempre condivise sulla piattaforma moodle dei vari moduli in cui insegno (https://elearning.uniroma1.it/).
Le lezioni, in questo periodo , sono svolte in modalità "blended" (in presenza e a distanza) in maniera sincrona utilizzando la piattaforma ZOOM o MEET a seconda delle modalità concordate nei vari Corsi di Laurea in cui insegno, seguendo il calendario delle lezioni fornito dal Corso di Laurea.

 

Dear students,

All lessons and news related to the teaching activities are always shared on the moodle platform of the various modules I teach in (https://elearning.uniroma1.it/).

The lessons, in this period, are carried out in blended mode (with students in the classroom and online) using the ZOOM or MEET platform according to the methods agreed on in the various Degree Courses. The lessons take place following the schedules of lessons provided by the Degree Courses.

Previo appuntamento concordato tramite e-mail: valeria.panebianco@uniroma1.it

By email appointment: valeria.panebianco@uniroma1.it

CV

PERSONAL INFORMATION Valeria Panebianco

E-mail address: valeria.panebianco@uniroma1.it
WORK EXPERIENCE

09/2019 Present Associate Professor of Radiology at Department of Radiological Sciences, Oncology & Pathology
Sapienza University of Rome, Rome (Italy)
Qualified to Full professor of Radiology ASN 2016
Responsible, Advanced MR & CT Imaging Division at U.O.C. of Radiology (Dir. Prof. C. Catalano) Coordinator, Prostate Unit

2002 2019 Specialist Radiologist
Department of Radiology at Department of Radiological Sciences, Oncology & Pathology, Policlinico Umberto I, Rome (Italy)

1999 2002 Specialist Radiologist
Department of Emergency, Policlinico Umberto I, Rome (Italy)

EDUCATION AND TRAINING

2003 2007 Residency in Nuclear Medicine EQF level8
Sapienza University of Rome, Rome (Italy)

1998 2002 Volunteer Assistant
Department of Radiology at Department of Radiological Sciences, Oncology & Pathology, Policlinico Umberto I, Rome (Italy)
Reasearch in urogenital and abdominal CT scan - MRI

1994 1998 Residency in Diagnostic Imaging & Images Sciences
Sapienza Unviersity of Rome, Rome (Italy) EQF level 8

1988 1993 Degree in Medicine and Surgery
Sapienza University of Rome, Rome (Italy)
EQF level 7

PERSONAL SKILLS

Mother tongue Italian,
Additional language English

ADDITIONAL INFORMATION

National and International
Appointments

2020-2021: Faculty Member, PhD on Network Oncology and Precision Medicine
2019-Today: ACR international representative, PI-RADS (Prostate Imaging Reporting and Data System) Committee of American College of Radiology /ACR).
2019-Today: Member, Committee of the STITCH (Sapienza information-based Technology InnovaTion Center for Health)
2017-Today: Faculty Member and Promotor, EAU (European Association of Urology) / ESU (European Schoolof Urology) MRI Masterclass in Prostatecancer.
2016-Today: Member and Reviser, ACI (Accreditation Council in Imaging) Reviewing Committee, EBR (European Board of Radiology).
2014-Today: Member, Genitourinary Scientific Sub-Committee of the ECR (European Congress of Radiology)
2011-Today: Faculty Member and Promoter, ESUR (European Society of Urogenital Radiology) Teaching Courses on Prostate MRI.
2010-Today: Faculty Member and Member of the working group on prostate cancer, ESUR (European Society of Urogenital Radiology)
2015-2018: President, Italian Chapter dell ISMRM (International Society of Magnetic Resonance in Medicine).
2014-2018: Member, AMPC (Annual Meeting Program Committee); ISMRM (International Society of Magnetic Resonance in Medicine).

Scientific Activity
Author of:
- 174 printed papers on "peer-reviewed journals
- 40 Books(Chapters)
- 5 Books(Monographs)

- Impact Factor:43.21
- H-Index: 32

Area of Research:
- Urogenital imaging focused on MRI of the prostate gland and the urinary bladder
- Computed Tomography, single-slice and multi-slice spiral CT (kidneys, virtoscopy); image post- processing.

Scientific Papers
Most recent 40 publications:

Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy. Panebianco V.. Eur Urol. Oncol. 2021 Feb; 10;S2588-9311(21)00027-4

Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Del Giudice F. Eur Urol. 2020 Jan;77(1):101-109.

Overview of VI-RADS in Bladder Cancer. Pecoraro M. AJR Am J Roentgenol. 2020 Jun;214(6):1259-1268

DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations. Giganti F. Magn Reson Imaging. 2020 Apr;67:50-58.

Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Woo S, Eur Urol Oncol. 2020 Jun;3(3):306-315.

Staging of bladder cancer with multiparametric MRI. Juri H, Narumi Y, Panebianco V, Osuga K. Br J Radiol. 2020 Aug;93(1112):20200116.

Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review. Stabile A. Eur Urol Oncol. 2020 Apr;3(2):145-167.MRI of Bladder Cancer: Local and Nodal Staging. Caglic I. J Magn Reson Imaging. 2020 Sep;52(3):649-667.

Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study. Giganti F. Eur Radiol. 2020 Apr;30(4):2082-2090.

Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography? Cipollari S. Curr Opin Urol. 2020 May;30(3):377-386.

VI-RADS for Bladder Cancer: Current Applications and Future Developments. Panebianco V. J Magn Reson Imaging. 2020 Sep 17.

Prostate cancer screening research can benefit from network medicine: an emerging awareness. Panebianco V. NPJ Syst Biol Appl. 2020 May 7;6(1):13.

Platinum Opinion Counterview: The Evidence Base for the Benefit of Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis is Sound. Padhani AR, Eur Urol. 2020 Sep;78(3):307-309.

Focus on the Quality of Prostate Multiparametric Magnetic Resonance Imaging: Synopsis of the ESUR/ESUI Recommendations on Quality Assessment and Interpretation of Images and Radiologists' Training. de Rooij M, Eur Urol. 2020 Oct;78(4):483-485.

VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic. Panebianco V, Eur Urol. 2020 Jul;78(1):e18-e20.

Reply to Charalampos Fragkoulis, Georgios Papadopoulos, and Konstantinos Ntoumas's Letter to the Editor re: Francesco Del Giudice, Giovanni Barchetti, Ettore De Berardinis, et al. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Eur Urol 2020;77:101-9. Del Giudice F. Eur Urol. 2020 Apr;77(4):e94-e95.

PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy Naive Men with Suspected Prostate Cancer: A Narrative Review. Schoots IG, AJR Am J Roentgenol. 2020 Aug 19.

Preoperative detection of VI-RADS (Vesical Imaging-Reporting and Data System) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time-to-cystectomy: time to reconsider the need for primary deep trans-urethral resection of bladder tumor in case of locally advanced disease? Del Giudice F, BJU Int. 2020 Jul 23.

ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training. de Rooij M Eur Radiol. 2020 Oct;30(10):5404-5416.

Barchetti, G. et al. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center. Eur. Radiol. (2019). doi:10.1007/s00330-019-06117-8

Panebianco, V., Narumi, Y., Barchetti, G., Montironi, R. & Catto, J. W. F. Should We Perform Multiparametric Magnetic Resonance Imaging of the Bladder Before Transurethral Resection of Bladder? Time to Reconsider the Rules. Eur. Urol. 76, 57 58 (2019).

Barret, E. et al. Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer. World J. Urol. 37, 429 436 (2019).

De Visschere, P. J. L. et al. A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer. Eur. Urol. Oncol. 2, 47 76 (2019).

Panebianco, V., Barentsz, J., Narumi, Y. & Catto, J. W. F. Reply to Jeremy Y.C. Teoh, Thomas R.W. Herrmann, and Marek Babjuk s Letter to the Editor re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI- RADS (Vesical Imaging-Reporting and Data System). Eur Urol 2018;74:294 306. Eur. Urol. 75, e29 e30 (2019).

Campa, R. et al. Improvement of prostate cancer detection combining a computer-aided diagnostic system with TRUS-MRI targeted biopsy. Abdom. Radiol. 44, 264 271 (2019).

Giganti, F. et al. The Evolution of MRI of the Prostate: The Past, the Present, and the Future. Am. J. Roentgenol. 213, 384 396 (2019).

Maggi, M. et al. Prostate Imaging Reporting and Data System 3 Category Cases at Multiparametric Magnetic Resonance for Prostate Cancer: A Systematic Review and Meta-analysis. Eur. Urol. Focus (2019). doi:10.1016/j.euf.2019.06.014

Richenberg, J. et al. The primacy of multiparametric MRI in men with suspected prostate cancer. Eur. Radiol. (2019). doi:10.1007/s00330-019-06166-zPapalia, R. et al. Accuracy of magnetic resonance imaging to identify pseudocapsule invasion in renal tumors. World J. Urol. (2019). doi:10.1007/s00345-019-02755-1

Kasivisvanathan, V. et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N. Engl. J. Med. (2018). doi:10.1056/NEJMoa1801993

Panebianco, V. et al. Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What s Next? Eur. Urol. (2018). doi:10.1016/j.eururo.2018.03.007

Panebianco, V. et al. Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer. Eur. Urol. Oncol. 1, 208 214 (2018).

Panebianco, V., Barentsz, J., Narumi, Y. & Catto, J. Reply to Andrea Necchi, Antonella Messina, and Alberto Briganti s Letter to the Editor re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol 2018;74:294 306. Eur. Urol. 74, e109 (2018).

Panebianco, V. et al. An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines. Insights Imaging 9, 87 101 (2018).

Panebianco, V. et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur. Urol. 74, 294 306 (2018).21.

Lai, S. et al. Early Markers of Cardiovascular Risk in Autosomal Dominant Polycystic Kidney Disease. Kidney Blood Press. Res. 42, 1290 1302 (2017).

Del Monte, M. et al. MRI/US fusion-guided biopsy: performing exclusively targeted biopsies for the early detection of prostate cancer. Radiol. Med. (Torino) (2017). doi:10.1007/s11547-017-0825-8.

Moore, C. M. et al. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations A Report of a European School of Oncology Task Force. Eur. Urol. 71, 648 655 (2017).

Maurer, T., Eiber, M., Fanti, S., Budäus, L. & Panebianco, V. Imaging for Prostate Cancer Recurrence. Eur. Urol. Focus 2, 139 150 (2016).

Panebianco, V. et al. Improving Staging in Bladder Cancer: The Increasing Role of Multiparametric Magnetic Resonance Imaging. Eur. Urol. Focus 2, 113 121 (2016).

Panebianco, V. et al. Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study. Urol. Oncol. Semin. Orig. Investig. 33, 17.e1- 17.e7 (2015).

Society Membership

2017-Today: European Society of Oncologic Imaging (ESOI) 2017-Today: International Cancer Imaging Society (ICIS)
2014-Today: International Society of Magnetic Resonance in Medicine (ISMRM) 2010-Today: Italian Chapter dell International Society of MR in Medicine (ISMRM) 2009-Today: European Society of Urogenital radiology (ESUR)
2000-Today: Radiological Society of North America (RSNA)
1995-Today: European Society of Radiology (ESR) - European Congress of Radiology (ECR) 1994-Today: Società Italiana di Radiologia Medica (SIRM)

Awards and Honors

2017: Honorary Membership of the Accademia Medica di Roma
2011: Award best presentation Members's day "3T DTI Fiber tracking in the depiction of perirprostatic nerve before and after nerve-sparing prostatectomy", 18th Annual Symposium ESUR
2009: Award best presentation Members's day "Comparison and correlation between1H-MRI in vivo prostate spectrosocpy at 1.5T and ex-vivo high resolution magic angle 1H-NMR Spectroscopy at 11T in the evaluation of new metabolite levels in prostate cancer", 16th European Symposium on Urogenital Radiology ESUR
2005: "Cum Laude" Award for the original research "Functional MRI of esophagus in healthy subjects: evaluation of normal patterns and future prospects" RSNA
2005: Best presentation Award on "Elaborazioni 3D", Convegno Nazionale della sezione di Radiologia Informatica, Verona 2005:

Title Journal Year
Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomy TRANSLATIONAL ANDROLOGY AND UROLOGY 2021
Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): international consensus -based guidelines on multiparametric Magnetic Resonance Imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy EUROPEAN UROLOGY ONCOLOGY 2021
Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36 EUROPEAN UROLOGY 2021
Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study BMC MEDICAL IMAGING 2021
ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging EUROPEAN RADIOLOGY 2021
The future direction of imaging in prostate cancer: MRI with or without contrast injection ANDROLOGY 2021
International multi-site initiative to develop an MRI-inclusive nomogram for side-specific prediction of extraprostatic extension of prostate cancer CANCERS 2021
Tocilizumab effects in COVID-19 pneumonia: role of CT texture analysis in quantitative assessment of response to therapy LA RADIOLOGIA MEDICA 2021
MRI of bladder cancer: local and nodal staging JOURNAL OF MAGNETIC RESONANCE IMAGING 2020
Reply to Charalampos Fragkoulis, Georgios Papadopoulos, and Konstantinos Ntoumas's letter to the editor re: Francesco Del Giudice, Giovanni Barchetti, Ettore De Berardinis, et al. Prospective assessment of vesical imaging reporting and data system (VI-RADS) and its clinical impact on the management of high-risk non–muscle-invasive bladder cancer patients candidate for repeated transurethral resection. Eur Urol 2020;77:101–9 EUROPEAN UROLOGY 2020
Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: A systematic review and meta-analysis EUROPEAN UROLOGY ONCOLOGY 2020
Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review EUROPEAN UROLOGY ONCOLOGY 2020
Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography? CURRENT OPINION IN UROLOGY 2020
Overview of VI-RADS in bladder cancer AMERICAN JOURNAL OF ROENTGENOLOGY 2020
High-intensity focused ultrasound for prostate cancer EXPERT REVIEW OF MEDICAL DEVICES 2020
VI-RADS scoring criteria for alternative risk-adapted strategies in the management of bladder cancer during the COVID-19 pandemic EUROPEAN UROLOGY 2020
Prostate cancer screening research can benefit from network medicine: an emerging awareness NPJ SYSTEMS BIOLOGY AND APPLICATIONS 2020
Elective procedures for prostate cancer in the time of Covid-19. a multidisciplinary team experience PROSTATE CANCER AND PROSTATIC DISEASES 2020
Chest CT score in COVID-19 patients. Correlation with disease severity and short-term prognosis EUROPEAN RADIOLOGY 2020
Focus on the quality of prostate multiparametric magnetic resonance imaging: synopsis of the ESUR/ESUI recommendations on quality assessment and interpretation of images and radiologists’ training EUROPEAN UROLOGY 2020
Course Code Year Course - Attendance
ADE AAF1433 2021/2022 Imaging and Radiotherapy techniques
INTERNSHIP FOR THE STATE EXAM - SURGERY AREA TPVES101 2021/2022 Medicine and Surgery
EQUIPMENT OF THE RADIOLOGICAL AREA 1052076 2021/2022 Imaging and Radiotherapy techniques
INTERNAL MEDICINE AND GENERAL SURGERY II 1023933 2021/2022 Medicine and Surgery
IMAGING DIAGNOSTICS 10596539 2021/2022 Medicine and Surgery
DIAGNOSTIC IMAGING 1038250 2021/2022 Medicine and Surgery
IMAGING DIAGNOSTICS 1025577 2021/2022 Medicine and Surgery
INTERNAL MEDICINE AND GENERAL SURGERY II 10596556 2021/2022 Medicine and Surgery
DIAGNOSTIC IMAGING 1038250 2021/2022 Medicine and Surgery
ADE AAF1433 2020/2021 Imaging and Radiotherapy techniques
INTERNSHIP FOR THE STATE EXAM - SURGERY AREA TPVES101 2020/2021 Medicine and Surgery
EQUIPMENT OF THE RADIOLOGICAL AREA 1052076 2020/2021 Imaging and Radiotherapy techniques
DIAGNOSTIC IMAGING 1038250 2020/2021 Medicine and Surgery
IMAGING DIAGNOSTICS 10596539 2020/2021 Medicine and Surgery
INTERNAL MEDICINE AND GENERAL SURGERY II 1023933 2020/2021 Medicine and Surgery
IMAGING DIAGNOSTICS 1025577 2020/2021 Medicine and Surgery
INTERNAL MEDICINE AND GENERAL SURGERY II 10596556 2020/2021 Medicine and Surgery
DIAGNOSTIC IMAGING 1038250 2020/2021 Medicine and Surgery
ADE AAF1433 2019/2020 Imaging and Radiotherapy techniques
EQUIPMENT OF THE RADIOLOGICAL AREA 1052076 2019/2020 Imaging and Radiotherapy techniques
IMAGING DIAGNOSTICS 1025577 2019/2020 Medicine and Surgery
INTERDISCIPLINARY COURSE I 1036306 2018/2019 Health Professions of Technical Sciences (diagnostic)
INTERDISCIPLINARY COURSE I 1036306 2017/2018 Health Professions of Technical Sciences (diagnostic)
INTERDISCIPLINARY COURSE I 1036306 2016/2017 Health Professions of Technical Sciences (diagnostic)
INTERDISCIPLINARY COURSE I 1036306 2016/2017 Health Professions of Technical Sciences (diagnostic)
Department
SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE
SSD

MED/36